How Much Does Testosterone Enanthate Cost in Massachusetts in 2026?

Retail Cash Prices Across Massachusetts Pharmacies

The average cash-pay price for a one-month supply of testosterone enanthate at Massachusetts retail pharmacies sits at $70 in 2026. This represents a standard 200 mg/mL vial (typically 1 mL or 5 mL depending on prescribed dose frequency) dispensed without insurance.

Prices vary by pharmacy chain and location. CVS and Walgreens locations in the Greater Boston area tend to price between $65 and $90 for a one-month supply, while independent pharmacies in western Massachusetts occasionally charge less. The manufacturer list price remains $120 per month, but almost no patient pays this figure at the counter. Testosterone enanthate has been available as a generic since its original FDA-approved formulation lost exclusivity decades ago, which keeps generic competition strong. A 5 mL multi-dose vial (1 to 000 mg total) can stretch to 4 or 5 weeks depending on prescribed dose, bringing the effective weekly cost to $14 to $18 for most patients on standard replacement protocols of 100 to 200 mg weekly [1].

The T-Trials program (N=790), published in the New England Journal of Medicine, confirmed that testosterone replacement in men over 65 with documented low testosterone improved sexual function, mood, and walking distance over 12 months [2]. These findings supported broader insurance formulary inclusion, which has progressively driven down out-of-pocket costs for Massachusetts residents.

Massachusetts Medicaid Coverage and Prior Authorization

Massachusetts Medicaid (MassHealth) covers testosterone enanthate for male hypogonadism, but requires prior authorization before dispensing. The PA process typically takes 3 to 5 business days.

To obtain approval, prescribers must document two morning serum total testosterone levels below 300 ng/dL drawn on separate days, plus signs or symptoms consistent with hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends this two-measurement confirmation approach before initiating therapy [3]. MassHealth follows this standard closely. Once approved, authorization typically lasts 12 months before renewal is required.

Patients denied on initial submission can appeal. Common denial reasons include missing a second confirmatory lab value or prescribing for off-label indications without supporting documentation. The MassHealth Drug Utilization Review Board reviews testosterone prescriptions quarterly, and approval rates for properly documented requests exceed 85% based on publicly available MassHealth pharmacy reports. Copays under MassHealth for approved testosterone enanthate prescriptions are $0 to $3.65 depending on the member's plan tier.

Commercial Insurance Coverage in Massachusetts

Most major commercial insurers in Massachusetts place testosterone enanthate on their preferred generic formulary tier. Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan, and Aetna plans sold on the Massachusetts Health Connector all cover generic testosterone enanthate.

Typical copays range from $10 to $45 per month depending on plan design. High-deductible health plans require patients to pay the negotiated rate (usually $40 to $60) until meeting their deductible. Plans that cover testosterone enanthate generally require the same clinical documentation as Medicaid: two confirmed low morning testosterone levels and a clinical diagnosis of hypogonadism.

Some plans impose step therapy, requiring patients to trial topical testosterone (gels or patches) before approving injectable testosterone enanthate. Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "Many men prefer injections for their reliability and lower long-term cost, and step therapy requirements can delay appropriate treatment by weeks" [4]. Patients who document skin reactions to topical formulations or cite transfer risk concerns (households with children or female partners) can often bypass step therapy on first appeal.

The American Urological Association's 2018 guideline on testosterone deficiency supports injectable testosterone enanthate as a first-line option, which strengthens appeal arguments against step therapy denials [5].

Compounded Testosterone Enanthate in Massachusetts

Compounded testosterone enanthate is legal in Massachusetts when dispensed through a licensed 503A compounding pharmacy with a valid patient-specific prescription. The average price runs approximately $80 per month.

Massachusetts regulates compounding pharmacies through the Board of Registration in Pharmacy, which enforces compliance with USP 797 sterile compounding standards. After the 2012 New England Compounding Center meningitis outbreak (which originated in Framingham, MA), state oversight of sterile compounding became significantly more rigorous. Current 503A pharmacies operating in Massachusetts must pass annual inspections and maintain batch testing records.

Why would a patient choose compounded testosterone at $80 when retail generic costs $70? Concentration customization is the primary reason. Standard manufactured vials come in 200 mg/mL concentration. Compounding pharmacies can prepare 250 mg/mL or 300 mg/mL concentrations, reducing injection volume for patients on higher doses. They can also compound in grape seed oil or MCT oil carriers for patients who react to the cottonseed oil base in most commercial products.

503B outsourcing facilities can also ship to Massachusetts prescribers for in-office administration, though these products cannot be dispensed directly to patients for home use without a 503A patient-specific prescription. The FDA's compounding quality page outlines the distinction between 503A and 503B pathways [6].

Telehealth Prescribing of Testosterone in Massachusetts

Massachusetts permits telehealth prescribing of testosterone enanthate. The state's 2020 telehealth parity law (Chapter 260 of the Acts of 2020) requires insurers to cover telehealth visits at the same rate as in-person appointments, and this extends to controlled substance prescriptions when the provider establishes a legitimate patient relationship.

For Schedule III substances like testosterone, Massachusetts does not require an in-person exam prior to telehealth prescribing, provided the prescriber conducts an adequate evaluation via synchronous audio-video visit. Lab work must still be completed at a draw site. Patients in Springfield, Worcester, Cape Cod, or the Berkshires gain the same access to endocrinology or urology specialists as those in Boston through telehealth platforms.

The DEA's updated telemedicine prescribing rule finalized in late 2025 codified the ability for providers to prescribe Schedule III through V controlled substances via telehealth after a video evaluation, removing the temporary COVID-era flexibilities in favor of permanent authorization [7]. Massachusetts telehealth TRT clinics typically charge $99 to $199 for an initial consultation, with follow-up visits every 3 to 6 months running $75 to $150.

Discount Programs and Savings Cards

Several manufacturer and third-party discount programs reduce testosterone enanthate costs for Massachusetts patients without insurance or with high copays.

GoodRx, RxSaver, and SingleCare consistently show testosterone enanthate 200 mg/mL (1 mL vial) priced between $35 and $55 at Massachusetts pharmacies when using their free discount cards. These programs work at CVS, Walgreens, Rite Aid, Costco, and most independent pharmacies. Costco's member pharmacy pricing (available to non-members in Massachusetts under state pharmacy access law) often represents the lowest retail option at $30 to $40 per vial.

Mark Cuban's Cost Plus Drugs offers testosterone cypionate (the closely related ester with identical clinical effects) at transparent markup pricing, though testosterone enanthate specifically may have variable availability through this channel. For patients whose providers are flexible on ester choice, cypionate and enanthate produce equivalent pharmacokinetics according to comparative studies [8].

Patients using GoodRx or similar discount cards cannot combine them with insurance. The optimal strategy: check both your insurance copay and the discount card price, then use whichever is lower at the point of sale. Massachusetts pharmacists are required to inform patients if a cash price is lower than their insurance copay under MGL Chapter 175, Section 2DD.

How to Minimize Your Total Out-of-Pocket Cost

The cheapest pathway depends on your insurance status. Here is a decision framework for Massachusetts residents:

MassHealth members: Submit PA documentation through your prescriber. Your copay will be $0 to $3.65 once approved. Total annual cost: under $44.

Commercial insurance with generic tier coverage: Use your plan's preferred pharmacy. Expect $10 to $45 per month. Annual cost: $120 to $540. Verify with your plan whether mail-order (90-day supply) offers a lower per-unit price.

Uninsured or high-deductible plan: Compare GoodRx pricing across local pharmacies. Costco pharmacy and Walmart pharmacy typically show the lowest prices. Target $35 to $55 per month. Annual cost: $420 to $660.

Patients needing custom concentrations: Licensed 503A compounding pharmacy. Expect $80 per month ($960 annually) but with the benefit of customized carrier oil and concentration.

A 2020 analysis in the Journal of the Endocrine Society found that injectable testosterone formulations cost 60% to 80% less annually than topical gels when comparing out-of-pocket expenditures, making enanthate one of the most cost-effective long-term TRT options regardless of state [9].

What Affects Price Variation in Massachusetts

Several factors create the $35 to $120 spread in testosterone enanthate pricing across Massachusetts pharmacies.

Pharmacy purchasing power matters. Large chains negotiate volume discounts from wholesalers like McKesson and AmerisourceBergen, but their retail markup can negate savings. Independent pharmacies sometimes pass wholesale savings directly to cash-pay patients. Geographic location plays a smaller role than purchasing channel: a CVS in Pittsfield charges roughly the same as one in Cambridge for the same NDC.

Vial size creates confusion. A 1 mL vial (200 mg) costs less per purchase but more per milligram than a 5 mL vial (1 to 000 mg). Patients on stable long-term therapy should ask their provider to prescribe the 5 mL multi-dose vial when possible. The per-month cost drops by approximately 25% to 30% compared to single-dose vials. Storage is straightforward: room temperature, protected from light, used within 28 days of first puncture per USP guidelines.

Generic manufacturer also influences pricing. Hikma, Perrigo, and Sun Pharmaceutical all produce testosterone enanthate for the US market. Pharmacy purchasing decisions between these manufacturers shift quarterly based on contract terms, which explains why pricing at the same pharmacy can change month to month without obvious reason.